Empty lipid nanoparticles (eLNPs) with adjuvant activity induce potent immune responses

Area of Science:

• Vaccinology
• Immunology
• Nanotechnology

Background:

• Mass vaccination is key for herd immunity against contagious diseases.
• Subunit protein vaccines offer safety and efficacy but require potent adjuvants.
• Current vaccine development needs adjuvants that enhance both humoral and cellular immunity.

Purpose of the Study:

• To evaluate empty lipid nanoparticles (eLNPs) as a novel vaccine adjuvant.
• To assess the capacity of eLNPs to amplify humoral and cellular immune responses.
• To explore the potential of eLNPs for next-generation vaccine development.

Main Methods:

• Characterization of empty lipid nanoparticles (eLNPs) using electron microscopy and nanoflow cytometry.
• Assessment of humoral immune response via ELISA and neutralization assays.
• Evaluation of cellular immune response using flow cytometry.

Main Results:

• eLNPs induced significantly higher neutralizing antibody titers than aluminum-based adjuvants.
• A strong, durable medium- to long-term T-cell response was observed with eLNPs.
• Increased follicular helper T cell proliferation, germinal center response, and memory response were noted.

Conclusions:

• Empty lipid nanoparticles (eLNPs) effectively enhance both humoral and cellular immunity.
• eLNPs demonstrate significant potential as a novel adjuvant for vaccine development.
• The findings suggest clinical translatability for eLNP-based vaccine formulations.